HOLLISTON, Mass., July 21, 2009 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that on June 26, 2009 it was added to the Russell 2000(R) Index following the Russell Investment Group’s annual reconstitution of its comprehensive set of U.S. and global equity indexes.
